Dexmethylphenidate Hydrochloride
Overview
Dexmethylphenidate Hydrochloride is the d-threo-enantiomer of the racemic methylphenidate hydrochloride, used as a central nervous system stimulant. It is primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.
API suppliers (5)
Suppliers of Dexmethylphenidate Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
1 of 5 holds a GMP certificate on record in the EU or UK registers
- CURIA MISSOURI INC1 active DMF
- PURISYS LLCUnited States1 active DMF
- SPECGX LLCUnited States1 active DMF
- Alkem Laboratories LimitedIndia1 active DMF GMP on record
- Siegfried LTDUnited Kingdom1 active DMF
Therapeutic areas
Do you supply Dexmethylphenidate Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.